Gonadorelin
GnRH
Gonadorelin corresponds to GnRH, the releasing hormone for LH and FSH. LHRH Ferring is an approved gonadorelin diagnostic medicine in Germany.
Approvals
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
Gonadorelin is the defined GnRH decapeptide sequence. The German approval applies to LHRH Ferring as a diagnostic medicine.
- Human research
- Moderate
- Replication
- Single research group
- Clinical endpoints
- Surrogate measures
- Safety
- Limited characterization
- Approval
- DE · Approved
The dimensions are presented separately and are not combined into an overall score.
What the source shows
The study examined a pulsatile pump in men with congenital hypogonadotropic hypogonadism.
- Pulsatile gonadorelin in congenital hypogonadotropic hypogonadismHuman study2019
U.S. National Library of Medicine (PubMed)
Accessed:
Research gaps
- ·The German diagnostic approval and pump treatment are not equivalent to arbitrary isolated injections.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
Pulsatile pituitary stimulation is central to its hormonal response.
- Pulsatile gonadorelin in congenital hypogonadotropic hypogonadismHuman study2019
U.S. National Library of Medicine (PubMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Safety has not been adequately studied.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·The German diagnostic approval and pump treatment are not equivalent to arbitrary isolated injections.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- LHRH Ferring 0,1 mg/1 ml: German prescribing informationPrescribing information2024
Ferring Arzneimittel GmbH
Accessed:
Sources
Sources checked: · Version 2
- Pulsatile gonadorelin in congenital hypogonadotropic hypogonadismHuman study2019
U.S. National Library of Medicine (PubMed)
Accessed:
- LHRH Ferring 0,1 mg/1 ml: German prescribing informationPrescribing information2024
Ferring Arzneimittel GmbH
Accessed: